Caplin Point's Caplin Steriles wins US FDA nod for Linezolid Injection

• Caplin Steriles, a Caplin Point subsidiary, received US FDA approval for Linezolid Injection 600mg/300mL.
• The approved injection is a generic equivalent of Pfizer’s ZYVOX, used to treat severe bacterial infections like pneumonia and resistant skin infections.
• The original product had US sales of approximately $23 million for the 12 months ending October 2025.
• Caplin Steriles has secured 44 FDA approvals out of 53 Abbreviated New Drug Applications (ANDAs) filed.
• Caplin Point Laboratories reported an 18% rise in net profit and a 10.6% increase in revenue for Q2FY26.

Why It Matters: It provides a new generic option for critical infection treatment.